New study aims to decode healthy newborn brain chemistry

NCT ID NCT07585149

Recruiting now Knowledge-focused Sponsor: University College Cork Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study measures normal levels of brain-specific proteins in healthy full-term newborns. Researchers will analyze blood samples from 150 babies to create a reference range for these proteins. This could help doctors spot brain injuries earlier in the future. No treatment or drug is being tested.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to: If successful, this could help doctors interpret brain injury tests in newborns, leading to earlier diagnosis and treatment.
What could go wrong: This is an observational study, not a treatment trial. It only establishes normal ranges; it does not test any therapy or intervention.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for BIOMARKER IN EARLY DIAGNOSIS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

BIOMARKER IN EARLY DIAGNOSIS NEONATAL REFERENCE INTERVALS

Contacts and locations

Locations

Department of Paediatric and Child Health
RECRUITING

Cork, T12 DC4C, Ireland

More trials for these conditions

Other studies related to the condition(s) this trial covers.